{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:40:15Z","timestamp":1780569615583,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.metabol.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T10:01:26Z","timestamp":1469008886000},"page":"1498-1507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Associations of fibroblast growth factor 23 with urate metabolism in patients with chronic kidney disease"],"prefix":"10.1016","volume":"65","author":[{"given":"Teppei","family":"Sakoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Tsuchihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Yoshitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Katafuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Shikuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2016.07.005_bb0005","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1517\/17460441.2.9.1251","article-title":"Drug discovery for hyperuricemia","volume":"2","author":"Anzai","year":"2007","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.metabol.2016.07.005_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","article-title":"Relationship of uric acid with progression of kidney disease","volume":"50","author":"Chonchol","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2016.07.005_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/BOR.0b013e328032781a","article-title":"New insights into renal transport of urate","volume":"19","author":"Anzai","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2016.07.005_bb0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1525-139X.2007.00308.x","article-title":"Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease","volume":"20","author":"Stubbs","year":"2007","journal-title":"Semin Dial"},{"key":"10.1016\/j.metabol.2016.07.005_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2016.07.005_bb0035","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2016.07.005_bb0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2016.07.005_bb0045","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2016.07.005_bb0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00424-003-1084-1","article-title":"Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na\/Pi transporter","volume":"446","author":"Segawa","year":"2003","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.metabol.2016.07.005_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000107069","article-title":"New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter","volume":"27","author":"Miyamoto","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0060","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ki.2008.643","article-title":"Latest findings in phosphate homeostasis","volume":"75","author":"Pri\u00e9","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2016.07.005_bb0065","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0070","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar3769","article-title":"The independent association between parathyroid hormone levels and hyperuricemia: a national population study","volume":"14","author":"Hui","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.metabol.2016.07.005_bb0075","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jbmr.286","article-title":"Serum uric acid is associated with bone health in older men: a cross-sectional population-based study","volume":"26","author":"Nabipour","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2016.07.005_bb0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2169\/internalmedicine.31.807","article-title":"Renal handling of urate in two patients with hyperuricemia and primary hyperparathyroidism","volume":"31","author":"Hisatome","year":"1992","journal-title":"Intern Med"},{"key":"10.1016\/j.metabol.2016.07.005_bb0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2796.1998.00366.x","article-title":"Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment","volume":"244","author":"Valdemarsson","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2016.07.005_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4615-5381-6_11","article-title":"Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout","volume":"431","author":"Takahashi","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0095","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0026-0495(98)90267-0","article-title":"Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout","volume":"47","author":"Takahashi","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2016.07.005_bb0100","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00467-012-2110-3","article-title":"Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function","volume":"27","author":"Bacchetta","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0105","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2215\/CJN.02740311","article-title":"Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study","volume":"6","author":"Guti\u00e9rrez","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.transproceed.2013.10.043","article-title":"Fibroblast growth factor-23 levels are associated with uric acid but not carotid intima media thickness in renal transplant recipients","volume":"46","author":"Asicioglu","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.metabol.2016.07.005_bb0115","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2016.07.005_bb0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005344-199608000-00012","article-title":"Effects of losartan on renal function in patients with essential hypertension","volume":"28","author":"Fauvel","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1254\/jphs.10064SC","article-title":"Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters","volume":"114","author":"Nakamura","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.metabol.2016.07.005_bb0130","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0135","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2016.07.005_bb0140","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","article-title":"Forging forward with 10 burning questions on FGF23 in kidney disease","volume":"21","author":"Wolf","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0145","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.07.005_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/hmg\/ddp489","article-title":"Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms","volume":"19","author":"van der Harst","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2016.07.005_bb0155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40620-015-0178-0","article-title":"Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients","volume":"28","author":"Bech","year":"2015","journal-title":"J Nephrol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/ar3191","article-title":"A proposal for identifying the low renal uric acid clearance phenotype","volume":"12","author":"Indraratna","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.metabol.2016.07.005_bb0165","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0962-8924(00)01783-9","article-title":"PDZ domains in synapse assembly and signalling","volume":"10","author":"Garner","year":"2000","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0170","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1046\/j.1523-1755.2003.00266.x","article-title":"PDZK1: I. a major scaffolder in brush borders of proximal tubular cells","volume":"64","author":"Gisler","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2016.07.005_bb0175","doi-asserted-by":"crossref","first-page":"11957","DOI":"10.1073\/pnas.182412699","article-title":"PDZ-domain interactions and apical expression of type IIa Na\/P(i) cotransporters","volume":"99","author":"Hernando","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2016.07.005_bb0180","doi-asserted-by":"crossref","first-page":"F321","DOI":"10.1152\/ajprenal.00093.2012","article-title":"NHERF-1 and the regulation of renal phosphate reabsoption: a tale of three hormones","volume":"303","author":"Weinman","year":"2012","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0185","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ndt\/gfm672","article-title":"Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23","volume":"23","author":"Marsell","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2016.07.005_bb0190","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1172\/JCI7103","article-title":"Effects of Npt2 gene ablation and low-phosphate diet on renal Na(+)\/phosphate cotransport and cotransporter gene expression","volume":"104","author":"Hoag","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.07.005_bb0195","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0026-0495(98)90056-7","article-title":"The effect of menopause on serum uric acid levels in non-obese healthy women","volume":"47","author":"Wingrove","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2016.07.005_bb0200","doi-asserted-by":"crossref","first-page":"126","DOI":"10.6118\/jmm.2014.20.3.126","article-title":"The association between serum uric acid level and incidence of metabolic syndrome according to menopausal status in Korean women","volume":"20","author":"Joo","year":"2014","journal-title":"J Menopausal Med"},{"key":"10.1016\/j.metabol.2016.07.005_bb0205","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(99)92381-4","article-title":"Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia","volume":"354","author":"Sumino","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2016.07.005_bb0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15257770.2010.551645","article-title":"The effect of female hormones upon urate transport systems in the mouse kidney","volume":"30","author":"Takiue","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.metabol.2016.07.005_bb0215","first-page":"132","article-title":"Uric acid elimination in the urine","volume":"147","author":"Marangella","year":"2005","journal-title":"Pathophysiological implications Contrib Nephrol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0220","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1038\/srep03755","article-title":"ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload","volume":"4","author":"Matsuo","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2016.07.005_bb0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10157-013-0806-8","article-title":"Uric acid transporter ABCG2 is increased in the intestine of the 5\/6 nephrectomy rat model of chronic kidney disease","volume":"18","author":"Yano","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.metabol.2016.07.005_bb0230","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.metabol.2013.09.018","article-title":"Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo","volume":"63","author":"Chen","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2016.07.005_bb0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1681\/ASN.2009080795","article-title":"Dietary fructose inhibits intestinal calcium absorption and induces vitamin D insufficiency in CKD","volume":"21","author":"Douard","year":"2010","journal-title":"J Am Soc Nephrol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:11:05Z","timestamp":1758427865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049516300695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0026049516300695"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2016.07.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of fibroblast growth factor 23 with urate metabolism in patients with chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}